BlackRock’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$182M Buy
3,577,091
+237,534
+7% +$12.1M ﹤0.01% 1661
2025
Q1
$150M Sell
3,339,557
-95,071
-3% -$4.28M ﹤0.01% 1740
2024
Q4
$142M Buy
3,434,628
+66,471
+2% +$2.75M ﹤0.01% 1854
2024
Q3
$131M Buy
3,368,157
+130,108
+4% +$5.07M ﹤0.01% 1908
2024
Q2
$111M Buy
3,238,049
+785,776
+32% +$26.9M ﹤0.01% 1950
2024
Q1
$61.6M Sell
2,452,273
-9,477
-0.4% -$238K ﹤0.01% 2285
2023
Q4
$72.7M Buy
2,461,750
+348,341
+16% +$10.3M ﹤0.01% 2228
2023
Q3
$66.8M Buy
2,113,409
+83,034
+4% +$2.62M ﹤0.01% 2204
2023
Q2
$52.5M Buy
2,030,375
+320,549
+19% +$8.29M ﹤0.01% 2405
2023
Q1
$41.1M Sell
1,709,826
-426,851
-20% -$10.3M ﹤0.01% 2542
2022
Q4
$41.7M Buy
2,136,677
+387,328
+22% +$7.55M ﹤0.01% 2557
2022
Q3
$36.8M Buy
1,749,349
+353,337
+25% +$7.42M ﹤0.01% 2650
2022
Q2
$27.2M Buy
1,396,012
+613,182
+78% +$11.9M ﹤0.01% 2858
2022
Q1
$17.2M Buy
782,830
+10,732
+1% +$236K ﹤0.01% 3196
2021
Q4
$12.3M Buy
772,098
+161,533
+26% +$2.58M ﹤0.01% 3487
2021
Q3
$12.2M Buy
610,565
+2,831
+0.5% +$56.4K ﹤0.01% 3532
2021
Q2
$10.5M Sell
607,734
-153,105
-20% -$2.65M ﹤0.01% 3559
2021
Q1
$15.1M Buy
760,839
+205,950
+37% +$4.08M ﹤0.01% 3283
2020
Q4
$9.69M Buy
554,889
+132,920
+31% +$2.32M ﹤0.01% 3311
2020
Q3
$8.13M Sell
421,969
-3,569
-0.8% -$68.8K ﹤0.01% 3254
2020
Q2
$8.28M Buy
425,538
+168,803
+66% +$3.28M ﹤0.01% 3226
2020
Q1
$3.59M Buy
256,735
+75,566
+42% +$1.06M ﹤0.01% 3414
2019
Q4
$4.44M Buy
181,169
+146,114
+417% +$3.58M ﹤0.01% 3492
2019
Q3
$352K Buy
+35,055
New +$352K ﹤0.01% 4178